LeMaitre Vascular (LMAT) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on LeMaitre Vascular (LMAT) is Neutral.

The composite score behind that read is -0.03, weighing +0.26 of bullish evidence against -0.31 bearish.

LeMaitre Vascular last closed at $80.69, +1.32% on the session.

Against the IVW growth benchmark the position is +0.52% over the forecast window.

The read is built from 15 underlying insights — 5 bullish and 10 bearish.

Agreement across those insights is 67%.

10 graded predictions for LMAT so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks LeMaitre Vascular in the 32nd percentile on valuation and the 75th percentile on return on equity, where 100 is best.

LeMaitre Vascular is classified under Health Care / Health Care Equipment & Supplies, with a market capitalisation of $1.82B.

StockMap tracks LeMaitre Vascular as the 46th largest of the 140 companies it covers in the Health Care Equipment & Supplies industry, part of the Health Care sector.

Across that group the current two-week reads are 122 Neutral, 16 Moderate Underperform and 2 Moderate Outperform.

On that composite LeMaitre Vascular ranks 67th of 140 in the group, against a group median of -0.03.